Agree Realty Corporation

Fundamentals5.0
Price Action4.0
News Sentiment0.0
AI Rating
6.0

Key Drivers

  • Margin Strength
  • FCF Deficit
  • Rich Valuation

AI
AI Summary

6.0

ADC remains a high-quality net-lease REIT with strong occupancy, dividend growth, and a solid tenant base, but the investment case now hinges on whether management can keep funding accretive acquisitions and growth fast enough to justify a rich valuation in a higher-rate, higher-cost capital environment.

REIT‍
Rates‍
Valuation‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

5.0

Key Financial Insights:

  • Margin Strength
  • FCF Deficit
  • Rich Valuation

ADC has strong margins and a solid balance sheet, but weak free cash flow, low returns on capital, and a demanding valuation make the stock look stretched.

ADC
FCF

Price Behavior

4.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Downtrend intact
  • Support holding
  • Overhead supply

ADC remains in a bearish last-month downtrend, but a three-session bounce off $73.4 support leaves a short-term rebound possible only if it can reclaim the $76s.

bearish
watchlist
Support Level: $73.4–$74.0
Resistance Level: $76.0–$76.4, then ~$78.0

Fell about 7.6% over the last month, then bounced for three sessions off $73.39

Sentiment & News

0.0

Key News Insights:

  • Record execution
  • Pipeline progress
  • Mixed ownership

Agree Realty remains a strong income REIT story with record investment activity, dividend growth, and raised guidance, while ADC Therapeutics and peers continue advancing clinical and funding catalysts.

REITs
Biotech

The news is constructive for Agree Realty's earnings and dividend outlook, while ADC Therapeutics stays a catalyst-driven name dependent on clinical and regulatory progress